Last year, Neuronetics Inc generated 86.98M USD for its biggest-performing segment, Clinic revenue. The United States made the largest contribution, accounting for 146.05M USD last year. For the latest quarter, Neuronetics Inc reported the revenue of 21.53M USD for the period ending 2026-03-31, which came from the top-performing segment, Clinic revenue. United States contributed the highest revenue, at 40.57M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Clinic revenue

Treatment sessions

NeuroStar Advanced Therapy System

Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Clinic revenue

86.98M(58.31%)

--(--)

Treatment sessions

44.41M(29.77%)

51.45M(73.03%)

51.65M(72.39%)

45.43M(69.67%)

42.20M(76.29%)

35.30M(71.69%)

41.47M(66.18%)

NeuroStar Advanced Therapy System

15.54M(10.42%)

16.09M(22.84%)

17.09M(23.95%)

17.39M(26.66%)

10.87M(19.65%)

11.95M(24.27%)

19.11M(30.50%)

Other

2.24M(1.50%)

2.91M(4.13%)

2.61M(3.66%)

2.39M(3.66%)

2.25M(4.06%)

1.99M(4.05%)

2.08M(3.31%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

United States

146.05M(97.92%)

68.04M(96.59%)

69.34M(97.18%)

63.41M(97.24%)

53.45M(96.63%)

47.52M(96.50%)

60.76M(96.97%)

51.48M(97.54%)

39.85M(98.57%)

31.58M(92.25%)

International

3.11M(2.08%)

2.40M(3.41%)

2.01M(2.82%)

1.80M(2.76%)

1.86M(3.37%)

1.73M(3.50%)

1.90M(3.03%)

1.30M(2.46%)

580.00K(1.43%)

2.65M(7.75%)